A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...

U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a ...

Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

A retired HGV driver was the first person in the world to take part in a clinical trial to extend the lifespan of blood ...

By Karen Roman Biopharmaceutical company Medera Inc. said it completed patient enrollment for Cohort B of its clinical trial ...

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...

Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...

A five-year-old boy who received the world's most expensive drug as a baby has made "incredible progress" and can walk ...

GEN’s first virtual event of 2026—we present a group of outstanding researchers and thought-leaders to discuss the latest advances and challenges in delivering genetic therapies.

The global cell and gene therapy third-party logistics market size was valued at USD 1.81 billion in 2025 and is predicted to ...

Abu Dhabi successfully completes its first gene therapy for genetic blood disorders, revolutionizing treatment approaches for ...